The FDA is targeting telehealth marketing of GLP-1 drugs. Who’s prescribing them? Medical groups face ‘tricky’ questions when partners make misleading claims By Katie PalmerMarch 12, 2026

The FDA is targeting telehealth marketing of GLP-1 drugs. Who’s prescribing them? Medical groups face ‘tricky’ questions when partners make misleading claims By Katie PalmerMarch 12, 2026 Katie Palmer is investigating how telehealth is driving the consumerization of drugs in the series The VirtualRX Boom. Here is Part 1 and Part 2. https://www.statnews.com/2026/03/12/fda-telehealth-marketing-glp1-prescribers-behind-warning-letters/